Trademarkia Logo

Canada

C$
INNOVUS PHARMA
REGISTERED

on 22 Feb 2021

Last Applicant/ Owned by

INNOVUS PHARMACEUTICALS INC.

c/o Legal373 Inverness Parkway, Suite 206Englewood, CO 80112

US

Serial Number

1913085 filed on 2th Aug 2018

Registration Number

TMA1094157 registered on 22nd Feb 2021

Registration expiry Date

22nd Feb 2031

Correspondent Address

MILTONS IP/P.I.

#200-15 Fitzgerald Road,Ottawa,

ONTARIO

CA

K2H9G1

INNOVUS PHARMA

Trademark usage description

medicated and pharmaceutical preparations and substances, namely, medicated preparations for the general health and well-being of the colon, prostate, Read More

Classification Information


Class [005]
Medicated and pharmaceutical preparations and substances, namely, medicated preparations for the general health and well-being of the colon, prostate, bladder, brain and vision; Medicated and pharmaceutical preparations and substances, namely, medicated preparations to improve sexual performance, allergy symptom relief, sleeping aids, blood sugar management, pain management and increasing muscle mass


Classification kind code

11

Class [010]
Medical instruments, apparatus, and equipment for use in the delivery of pharmaceutical preparations and substances, namely, anesthetic delivery apparatus and implantable subcutaneous drug delivery devices


Classification kind code

11

Mark Details


Serial Number

1913085

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 135
on 11th Feb 2021
Amendment to Application
Submitted for opposition 42
on 18th Nov 2020
Advertised
Submitted for opposition 27
on 23rd Oct 2020
Approval Notice Sent
Submitted for opposition 26
on 23rd Oct 2020
Approved
Submitted for opposition 22
on 19th Aug 2020
Search Recorded
Submitted for opposition 20
on 19th Aug 2020
Examiner's First Report
Submitted for opposition 87
on 30th Aug 2018
Rep for Service Changed
Submitted for opposition 31
on 6th Aug 2018
Formalized
Submitted for opposition 1
on 3rd Aug 2018
Created
Submitted for opposition 30
on 2th Aug 2018
Filed